Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: A large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II)

Cancer Causes and Control

Volumn 20, Issue 5, 2009, Pages 741-750

  Inoue, Manami ^a   Kurahashi, Norie ^a   Iwasaki, Motoki ^a   Tanaka, Yasuhito ^b   Mizokami, Masashi ^b   Noda, Mitsuhiko ^c   Tsugane, Shoichiro ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Cohort study; Hepatocellular carcinoma; High glucose; Metabolic factor; Overweight

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEPATITIS; HUMAN; JAPANESE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METABOLISM; OBESITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPATITIS C; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; POPULATION GROUPS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 67349222208     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-008-9287-6     Document Type: Article

References (46)

1. A Lonardo P Loria N Carulli 2008 Dysmetabolic changes associated with HCV: a distinct syndrome? Intern Emerg Med 3 99 108 10.1007/s11739-008-0127-1
2. E Bugianesi 2005 Review article: steatosis, the metabolic syndrome and cancer Aliment Pharmacol Ther 22 Suppl 2 40 43 10.1111/j.1365-2036.2005.02594.x (Pubitemid 41564381)
3. E Bugianesi C Zannoni E Vanni R Marzocchi G Marchesini 2004 Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship? Dig Liver Dis 36 165 173 10.1016/j.dld.2003.12.008
4. HB El-Serag H Hampel F Javadi 2006 The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence Clin Gastroenterol Hepatol 4 369 380 10.1016/j.cgh.2005.12.007
5. El-Serag HB, Hampel H, Javadi F (2007) The Editorial Board of the Cancer Statistics in Japan. Cancer statistics in Japan 2007. Foundation for Promotion of Cancer Research (FPFR), Tokyo
6. T Marugame T Matsuda K Kamo K Katanoda W Ajiki T Sobue 2007 Cancer incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries Jpn J Clin Oncol 37 884 891 10.1093/jjco/hym112
7. Y Shiratori S Shiina M Imamura N Kato F Kanai T Okudaira T Teratani G Tohgo N Toda M Ohashi 1995 Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan Hepatology 22 1027 1033
8. RH Eckel SM Grundy PZ Zimmet 2005 The metabolic syndrome Lancet 365 1415 1428 10.1016/S0140-6736(05)66378-7
9. A Russo M Autelitano L Bisanti 2008 Metabolic syndrome and cancer risk Eur J Cancer 44 293 297 10.1016/j.ejca.2007.11.005
10. CL Chen HI Yang WS Yang CJ Liu PJ Chen SL You LY Wang CA Sun SN Lu DS Chen CJ Chen 2008 Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan Gastroenterology 135 111 121 10.1053/j.gastro.2008.03.073
11. M Inoue M Iwasaki T Otani S Sasazuki M Noda S Tsugane 2006 Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan Arch Intern Med 166 1871 1877 10.1001/archinte.166.17.1871
12. K Kuriki K Hirose K Tajima 2007 Diabetes and cancer risk for all and specific sites among Japanese men and women Eur J Cancer Prev 16 83 89 10.1097/01.cej.0000228404.37858.40
13. MS Lai MS Hsieh YH Chiu TH Chen 2006 Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection Hepatology 43 1295 1302 10.1002/hep.21208
14. SH Jee H Ohrr JW Sull JE Yun M Ji JM Samet 2005 Fasting serum glucose level and cancer risk in Korean men and women JAMA 293 194 202 10.1001/jama.293.2.194
15. JM Yuan S Govindarajan K Arakawa MC Yu 2004 Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S Cancer 101 1009 1017 10.1002/cncr.20427
16. MM Hassan LY Hwang CJ Hatten M Swaim D Li JL Abbruzzese P Beasley YZ Patt 2002 Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus Hepatology 36 1206 1213 10.1053/jhep.2002.36780
17. HB El-Serag PA Richardson JE Everhart 2001 The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans Am J Gastroenterol 96 2462 2467 10.1111/j.1572-0241.2001.04054.x (Pubitemid 32769212)
18. P Lagiou H Kuper SO Stuver A Tzonou D Trichopoulos HO Adami 2000 Role of diabetes mellitus in the etiology of hepatocellular carcinoma J Natl Cancer Inst 92 1096 1099 10.1093/jnci/92.13.1096 (Pubitemid 30616486)
19. C La Vecchia E Negri A Decarli S Franceschi 1997 Diabetes mellitus and the risk of primary liver cancer Int J Cancer 73 204 207 10.1002/(SICI)1097- 0215(19971009)73:2<204::AID-IJC7>3.0.CO;2-#
20. JA Davila RO Morgan Y Shaib KA McGlynn HB El-Serag 2005 Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study Gut 54 533 539 10.1136/gut.2004.052167
21. W Ohishi S Fujiwara JB Cologne G Suzuki M Akahoshi N Nishi I Takahashi K Chayama 2008 Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study Cancer Epidemiol Biomarkers Prev 17 846 854 10.1158/1055-9965.EPI-07-2806
22. C Samanic G Gridley WH Chow J Lubin RN Hoover JF Fraumeni Jr 2004 Obesity and cancer risk among white and black United States veterans Cancer Causes Control 15 35 43 10.1023/B:CACO.0000016573.79453.ba
23. EE Calle C Rodriguez K Walker-Thurmond MJ Thun 2003 Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 1625 1638 10.1056/NEJMoa021423
24. H Moller A Mellemgaard K Lindvig JH Olsen 1994 Obesity and cancer risk: a Danish record-linkage study Eur J Cancer 30A 344 350 10.1016/0959-8049(94) 90254-2
25. K Rapp J Schroeder J Klenk S Stoehr H Ulmer H Concin G Diem W Oberaigner SK Weiland 2005 Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria Br J Cancer 93 1062 1067 10.1038/sj.bjc.6602819
26. A Wolk G Gridley M Svensson O Nyren JK McLaughlin JF Fraumeni HO Adam 2001 A prospective study of obesity and cancer risk (Sweden) Cancer Causes Control 12 13 21 10.1023/A:1008995217664
27. S Tsugane T Sobue 2001 Baseline survey of JPHC study-design and participation rate, Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases J Epidemiol 11 S24 S29
28. M Iida S Sato M Nakamura 2001 Standardization of laboratory test in the JPHC study, Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases J Epidemiol 11 S81 S86
29. M Nakamura S Sato T Shimamoto 2003 Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network J Atheroscler Thromb 10 145 153
30. SM Grundy JI Cleeman SR Daniels KA Donato RH Eckel BA Franklin DJ Gordon RM Krauss PJ Savage SC Smith Jr JA Spertus F Costa 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2735 2752 10.1161/CIRCULATIONAHA.105.169404
31. KG Alberti P Zimmet J Shaw 2006 Metabolic syndrome-a new world-wide definition, A Consensus Statement from the International Diabetes Federation Diabet Med 23 469 480 10.1111/j.1464-5491.2006.01858.x
32. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity (2006) New criteria for 'obesity disease' in Japan. Circ J 66:987-992. doi: 10.1253/circj.66.987
33. M Abdel-Hamid M El-Daly S El-Kafrawy N Mikhail GT Strickland AD Fix 2002 Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus J Clin Microbiol 40 1656 1659 10.1128/JCM.40.5.1656-1659.2002
34. Abdel-Hamid M, El-Daly M, El-Kafrawy S, Mikhail N, Strickland GT, Fix AD (1990) World Health Organization International classification of diseases and health related problem, 10th revision. World Health Organization, Geneva, Switzerland
35. Abdel-Hamid M, El-Daly M, El-Kafrawy S, Mikhail N, Strickland GT, Fix AD (2000) World Health Organization International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva, Switzerland
36. Abdel-Hamid M, El-Daly M, El-Kafrawy S, Mikhail N, Strickland GT, Fix AD (2007) Stata Corporation Stata Statistical Software. Stata Corporation, College Station, TX
37. MC Yu JM Yuan 2004 Environmental factors and risk for hepatocellular carcinoma Gastroenterology 127 S72 S78 10.1016/j.gastro.2004.09.018
38. N McIntyre 1978 Plasma lipids and lipoproteins in liver disease Gut 19 526 530 10.1136/gut.19.6.526 (Pubitemid 8363913)
39. CF Jan CJ Chen YH Chiu LS Chen HM Wu CC Huang MF Yen TH Chen 2006 A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10) Int J Obes (Lond) 30 794 799 10.1038/sj.ijo.0803204
40. D Siagris M Christofidou GJ Theocharis N Pagoni C Papadimitriou A Lekkou K Thomopoulos I Starakis AC Tsamandas C Labropoulou-Karatza 2006 Serum lipid pattern in chronic hepatitis C: histological and virological correlations J Viral Hepat 13 56 61 10.1111/j.1365-2893.2005.00655.x
41. KL Donnelly CI Smith SJ Schwarzenberg J Jessurun MD Boldt EJ Parks 2005 Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J Clin Invest 115 1343 1351 (Pubitemid 40629054)
42. M Ono T Saibara 2006 Clinical features of nonalcoholic steatohepatitis in Japan: evidence from the literature J Gastroenterol 41 725 732 10.1007/s00535-006-1876-0
43. K Hatanaka M Kudo T Fukunaga K Ueshima H Chung Y Minami Y Sakaguchi S Hagiwara A Orino Y Osaki 2007 Clinical characteristics of NonBNonC-HCC: comparison with HBV and HCV related HCC Intervirology 50 24 31 10.1159/000096309
44. E Hashimoto S Yatsuji H Kaneda Y Yoshioka M Taniai K Tokushige K Shiratori 2005 The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease Hepatol Res 33 72 76 10.1016/j.hepres.2005.09. 007
45. M Iwasaki T Otani S Yamamoto M Inoue T Hanaoka T Sobue S Tsugane 2003 Background characteristics of basic health examination participants: the JPHC Study Baseline Survey J Epidemiol 13 216 225
46. M Iwasaki S Yamamoto T Otani M Inoue T Hanaoka T Sobue S Tsugane 2006 Generalizability of relative risk estimates from a well-defined population to a general population Eur J Epidemiol 21 253 262 10.1007/s10654-006-0004-z